Dubois, F., Keller, M., Hoflack, J., Maille, E., Antoine, M., Westeel, V., . . . Levallet, G. (2019). Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial. Cancers (Basel).
Chicago Style CitationDubois, Fatéméh, et al. "Role of the YAP-1 Transcriptional Target CIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients With Tumor RASSF1A Gene Methylation From the Phase 3 IFCT-0002 Trial." Cancers (Basel) 2019.
MLA CitationDubois, Fatéméh, et al. "Role of the YAP-1 Transcriptional Target CIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients With Tumor RASSF1A Gene Methylation From the Phase 3 IFCT-0002 Trial." Cancers (Basel) 2019.